Rachel Tanner

Datos Biográficos

ID10040929
NOMBRERachel Tanner
NOMBRESRachel
APELLIDOTanner
FIRMATANNER R
AFILIACIONESUniversity of Oxford
ORCID0000-0003-3622-5984
VERIFICADONo
TOTAL DE OBRAS2
TOTAL DE CITAS0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2021
AÑO MÁS RECIENTE DE PUBLICACIÓN2024
ÍNDICE H0

  • Shared challenges to the control of complex intracellular neglected pathogens

    Open AccessRebecca Lynn Perez, Jemima Chase et al.ARTICLEFrontiers in Public Health2024

    The complex intracellular pathogens Mycobacterium tuberculosis , Mycobacterium leprae , Leishmania spp., and Burkholderia pseudomallei , which cause tuberculosis, leprosy, leishmaniasis, and melioidosis respectively, represent major health threats with a significant global burden concentrated in low- and middle-income countries. While these diseases vary in their aetiology, pathology and epidemiology, they share key similarities in the biological…

  • Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against Sars-CoV-2

    Open AccessMerryn Voysey, Sue Ann Costa Clemens et al.ARTICLEThe Lancet2021

    Background A safe and efficacious vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), if deployed with high coverage, could contribute to the control of the COVID-19 pandemic. We evaluated the safety and efficacy of the ChAdOx1 nCoV-19 vaccine in a pooled interim analysis of four trials. Methods This analysis includes data from four ongoing blinded, randomised, controlled trials done across the UK, Brazil, and South Afri…